Skip to content

Association Between Oral Hypofunction, Sarcopenia and Social Frailty in Community-dwelling Older Adults

Association Between Oral Hypofunction, Sarcopenia, and Social Frailty in Community-Dwelling Older Adults

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07658625
Acronym
OSSF
Enrollment
200
Registered
2026-06-22
Start date
2025-11-14
Completion date
2026-06-04
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Sarcopenic Subjects, Possible Sarcopenia, Sarcopenia(With Low ASM by BIM)

Keywords

Sarcopenia, Poor oral function, Social weakness, chew, Nutrition

Brief summary

Previous studies have provided a preliminary understanding of the likelihood of sarcopenia and the prevalence of sarcopenia in the elderly in the community. due to the interaction between physiological and social factors, this study aims to conduct a correlation study on muscle mass, oral function and social frailty in the elderly living in the community. This study,the Makizako social frailty screening index questionnaire and the Tilburg Frailty Indicator will be used to assess the social frailty status of the study participants. Correlation analysis with sarcopenia and oral dysfunction was also conducted to better understand the interaction between nutrition, physiology, and social connection in the elderly, which will be helpful for formulating relevant policies and promoting healthy aging in the future in extremely elderly countries.

Interventions

OTHERNon interventional study

NON

Sponsors

Chang Gung University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Group A-Inclusion Criteria: * 65 years old or above * general public or institutionalized for 3 months or more * those who accept the experimental design and are willing to sign the consent form * dietary sources are oral intake * those who are diagnosed as having possible sarcopenia by researchers Group B-Inclusion Criteria: * 65 years old or above * general public or institutionalized for 3 months or more * those who accept the experimental design and are willing to sign the consent form * dietary sources are oral intake * those who were determined by researchers to be non-probable sarcopenia Group A、B-

Exclusion criteria

* comorbidities, critical illness, pre- and post-major surgery, cancer, renal failure, liver failure, kidney disease, liver disease, malignant tumors within the past five years, inflammatory conditions (c-reactive protein \>10mg/dL) * severely malnourished people * long-term force-feeding

Design outcomes

Primary

MeasureTime frameDescription
Based on the results of empirical research on sarcopenia in Asian countries, a diagnostic consensus was established.Baseline* The cut-off point for abnormal grip strength is less than 28 kg for men and less than 18 kg for women * 6-meter walking speed less than 1.0 second/meter * 5-time chair stand test greater than or equal to 12 seconds * Short physical performance battery, SPPB greater than or equal to 9 points The above will be combined to determine whether sarcopenia is possible.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026